Amy Raskopf retweeted
🚨 10 million views. 24,000+ comments. Picked up by @BuzzFeed, @ScaryMommy, and @MSN.
And all we did was ask one question: “What’s your favorite way to practice microfeminism every day?”
Let’s be clear—this isn’t just a viral moment. It’s a reflection of something much deeper: Women are done whispering. They’re done tiptoeing. And they’re definitely done apologizing.
This is what happens when a birth control brand like PHEXXI leads with truth, autonomy, and humor.
I’m so proud that @Evofem is at the center of this cultural realignment—because that’s exactly what it is. This is about language, power, and putting ourselves first.
And we’re not done yet.
In the month of August, we’re getting ready to amplify even more voices around the issues that matter most—globally.
Something big is coming. Stay tuned!
#Microfeminism #StrongWomenStrongStandards #ReclaimYourTime #WomensHealth #Evofem #BuzzFeed #ScaryMommy #BoldMovesAhead
evofem.investorroom.com/2025…
Amy Raskopf retweeted
Don't miss this opportunity to learn more about women’s health, innovation, and the future of reproductive health. Oct 28th.
🌟 Join me on October 28th at 11:30 AM ET for a chat with @aditXt CEO Amro Albanna & @drdrew📺🎙️! We’ll share updates and answer your questions in a live Q&A. Submit your Qs by Oct 25!
Register here: lnkd.in/g8RfryVa #WomensHealth #Biotech #ReproductiveHealth #Healthcare
Amy Raskopf retweeted
NASDAQ: $EVFM With growing revenues from its FDA-approved #contraceptive & significant near-term upside from potential label expansion into #STI prevention, @Evofem CEO Saundra Pelletier sheds light on why $EVFM may be a stock to watch below.
#ad #womenshealth
Amy Raskopf retweeted
Emmy® Award-winning spokeswoman and actress, Annie Murphy sat down with Evofem’s CEO @Saundraceo to discuss our product and the options it provides to women during a time where their rights are under attack. Thank you @people @ness_atn. https://teapawt.net/t.co/C0MUrB3cDH
#womenshealth
Amy Raskopf retweeted
Investing for the times we live in -
Female Contraception Post Roe V. Wade
$EVFM @Evofem @Saundraceo #RoeVWade #RoeOverturned #WomensHealth #Phexxi
seekingalpha.com/article/452…
Amy Raskopf retweeted
via @NYTimes. Birth control options, like Phexxi, are even more critical now! nytimes.com/article/birth-co…
Amy Raskopf retweeted
The majority decision released today from the United States Supreme Court is an affront to all Americans, but especially American women. Listen as Evofem CEO, @Saundraceo provides her thoughts on today’s decision out of SCOTUS.
Amy Raskopf retweeted
Evofem Biosciences Announces Regulatory Submission in Mexico for Its Hormone-Free Contraceptive. Potential Commercialization in Mexico Under the Trademark Femidence™ Expected in Early 2023. $EVFM prn.to/3EZtm9G
Amy Raskopf retweeted
Evofem Biosciences Announces $10 Million Registered Direct Offering of Series B Preferred Stock -- Provides Runway into Q1 2022 $EVFM prn.to/3iSLdqj
Amy Raskopf retweeted
PLEASE SIGN and SHARE this petition to demand that the U.S. Department of Health and Human Services cover this important non-hormonal birth control option under insurance. contraceptivecoverage.com
Amy Raskopf retweeted
Evofem Biosciences Announces Publication in Peer-Reviewed Journal Advances in Therapy $EVFM prn.to/3kFvGeG
Amy Raskopf retweeted
On #WorldContraceptionDay we celebrate your right to choose a #contreception that works best for you.
We are especially proud to provide a hormone-free, on-demand prescription #birthcontrol option, Phexxi® (lactic acid, citric acid & potassium bitartrate)!
Amy Raskopf retweeted
In an interview with @Shape_Magazine, @annefranes, Emmy® Award-winning actress, spoke about her path to #nonhormonal #birthcontrol and her role as the face of our new "House Rules" campaign. https://teapawt.net/t.co/yeox0WQcMM #womenshealth
Amy Raskopf retweeted
.@InStyle's @KylieMGilbert spoke with @annefrances about her journey with birth control and being the face of our newly launched “House Rules" national campaign. Check it out here: https://teapawt.net/t.co/HQHoVXQ4xE $EVFM
Amy Raskopf retweeted
Evofem Biosciences to Present at LD Micro Invitational XI on Tuesday, June 8th at 1pm ET. Details in linked PR. $EVFM prn.to/3oMnYzK
Amy Raskopf retweeted
Evofem Biosciences Announces Pricing of $50 Million Public Offering $EVFM prn.to/3wdkQ2j
Amy Raskopf retweeted
New data on EVO100 for the prevention of chlamydia and gonorrhea in women to be presented at ISPOR 2021. More details in linked PR. $EVFM prn.to/3yfWd75
Amy Raskopf retweeted
"Consumers Respond to D2C Birth Control" — Thank you @MediaPost for covering @Evofem's "Get Phexxi" DTC ad campaign. $EVFM #Phexxi https://teapawt.net/t.co/sDJYI3r6jP


















